ATE205704T1 - 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen - Google Patents

5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen

Info

Publication number
ATE205704T1
ATE205704T1 AT96943884T AT96943884T ATE205704T1 AT E205704 T1 ATE205704 T1 AT E205704T1 AT 96943884 T AT96943884 T AT 96943884T AT 96943884 T AT96943884 T AT 96943884T AT E205704 T1 ATE205704 T1 AT E205704T1
Authority
AT
Austria
Prior art keywords
asa
modified release
drug containing
release drug
intestinal diseases
Prior art date
Application number
AT96943884T
Other languages
English (en)
Inventor
Svenn Kluever Jepsen
Soeren Halskov
Original Assignee
Ferring Farma Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE205704(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Farma Lab filed Critical Ferring Farma Lab
Application granted granted Critical
Publication of ATE205704T1 publication Critical patent/ATE205704T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96943884T 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen ATE205704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57595495A 1995-12-21 1995-12-21
PCT/DK1996/000551 WO1997023199A1 (en) 1995-12-21 1996-12-23 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases

Publications (1)

Publication Number Publication Date
ATE205704T1 true ATE205704T1 (de) 2001-10-15

Family

ID=24302375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943884T ATE205704T1 (de) 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen

Country Status (28)

Country Link
EP (1) EP0871434B2 (de)
JP (1) JP4714836B2 (de)
KR (2) KR100542544B1 (de)
CN (1) CN1155369C (de)
AT (1) ATE205704T1 (de)
AU (1) AU702934B2 (de)
BG (1) BG63484B1 (de)
BR (1) BR9612213A (de)
CA (1) CA2240281C (de)
CZ (1) CZ289290B6 (de)
DE (2) DE69615400T3 (de)
DK (1) DK0871434T4 (de)
EE (1) EE03740B1 (de)
ES (1) ES2149733T5 (de)
HK (1) HK1017615A1 (de)
HU (1) HU228856B1 (de)
IL (1) IL124858A (de)
IS (1) IS1834B (de)
NO (1) NO320498B1 (de)
NZ (1) NZ325201A (de)
PL (1) PL186790B1 (de)
PT (1) PT871434E (de)
RU (1) RU2181043C2 (de)
SI (1) SI0871434T2 (de)
SK (1) SK282669B6 (de)
TR (1) TR199801158T2 (de)
UA (1) UA67721C2 (de)
WO (1) WO1997023199A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
WO2000044353A1 (de) 1999-01-29 2000-08-03 Losan Pharma Gmbh Pharmazeutische zusammensetzungen
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
CN100506234C (zh) * 2001-10-15 2009-07-01 凡林有限公司 用于治疗溃疡性结肠炎和克罗恩病的含有5-氨基水杨酸的药物组合物的制备方法
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
EP1615619A2 (de) * 2003-04-23 2006-01-18 Ferring B.V. Sachet für pharmazeutische zubereitungen
EP1547601A1 (de) 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
RU2297835C1 (ru) 2005-09-26 2007-04-27 Закрытое акционерное общество "Партнер" Препарат для лечения неинфекционных воспалительных болезней кишечника
DK2004164T3 (en) * 2006-04-13 2018-10-29 Neurotech Pharmaceuticals Co Ltd PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF INFLAMMATORY DISEASES
RU2493829C2 (ru) * 2008-08-22 2013-09-27 РЕКИТТ БЕНКАЙЗЕР ХЕЛТКЭА (Ю Кей) ЛИМИТЕД Улучшение композиций или того, что имеет отношение к композициям
NZ592049A (en) 2008-10-03 2012-11-30 Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
EP2340812A1 (de) 2009-12-18 2011-07-06 Ferring International Center S.A. Granulat für pharmazeutische Präparate sowie Verfahren und Vorrichtungen zu ihrer Herstellung
RU2463055C2 (ru) * 2011-01-12 2012-10-10 Петр Леонидович Щербаков Способ лечения воспалительных заболеваний кишечника
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
US20150164920A1 (en) 2012-03-30 2015-06-18 Laboratorios Del Dr. Esteve S.A. Controlled release formulation comprising mesalamine
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
HU228856B1 (en) 2013-06-28
ES2149733T5 (es) 2008-05-01
DK0871434T3 (da) 2002-01-07
EE9800191A (et) 1998-12-15
BG102556A (en) 1999-02-26
JPH11510191A (ja) 1999-09-07
SI0871434T2 (sl) 2008-04-30
PL327323A1 (en) 1998-12-07
SK282669B6 (sk) 2002-11-06
BG63484B1 (bg) 2002-03-29
DE69615400T3 (de) 2008-08-07
AU702934B2 (en) 1999-03-11
PL186790B1 (pl) 2004-02-27
NO982904L (no) 1998-06-22
SI0871434T1 (en) 2002-04-30
IS1834B (is) 2002-11-15
KR100598714B1 (ko) 2006-07-10
IL124858A (en) 2003-03-12
IS4772A (is) 1998-06-15
NO320498B1 (no) 2005-12-12
HUP0001084A2 (hu) 2000-11-28
CN1155369C (zh) 2004-06-30
KR100542544B1 (ko) 2006-05-10
CA2240281C (en) 2007-02-27
DE871434T1 (de) 2001-04-05
TR199801158T2 (xx) 1998-09-21
DE69615400D1 (de) 2001-10-25
KR19990076584A (ko) 1999-10-15
SK83498A3 (en) 1999-01-11
CZ289290B6 (cs) 2001-12-12
CA2240281A1 (en) 1997-07-03
NO982904D0 (no) 1998-06-22
ES2149733T1 (es) 2000-11-16
UA67721C2 (en) 2004-07-15
IL124858A0 (en) 1999-01-26
HUP0001084A3 (en) 2000-12-28
AU1366197A (en) 1997-07-17
CN1207672A (zh) 1999-02-10
EP0871434A1 (de) 1998-10-21
NZ325201A (en) 1998-11-25
EE03740B1 (et) 2002-06-17
KR20050087886A (ko) 2005-08-31
DE69615400T2 (de) 2002-05-23
DK0871434T4 (da) 2008-04-07
BR9612213A (pt) 1999-12-28
ES2149733T3 (es) 2002-04-01
HK1017615A1 (en) 1999-11-26
RU2181043C2 (ru) 2002-04-10
JP4714836B2 (ja) 2011-06-29
PT871434E (pt) 2002-02-28
EP0871434B1 (de) 2001-09-19
EP0871434B2 (de) 2007-12-12
WO1997023199A1 (en) 1997-07-03
CZ194698A3 (cs) 1998-10-14

Similar Documents

Publication Publication Date Title
ATE205704T1 (de) 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen
RU95109905A (ru) Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта
DE69720985D1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
DE69634693D1 (de) Mehrfach ungesättigte omega-3 fettsäuren zur behandlung von entzündlichen darmerkrankungen in kapseln mit zeitabhängiger freisetzung
DE69629797D1 (de) Matrix zur gesteuerten freisetzung von arzneistoffen
DE69634776D1 (de) Verwendung eines r-nsaid als chemoschützendes mittel zur behandlung kolorektales krebs
ATE129893T1 (de) Orale dosierungsform mit verzögerter wirkstoffabgabe für die behandlung von intestinalen krankheiten.
EA199600028A2 (ru) Оральная композиция, содержащая s(+)-ибупрофен, и способ ее получения
DE69021214D1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
DE69025271D1 (de) Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen
DK0497956T3 (da) Præparater med reguleret frigivelse
ATE265851T1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
ATE15897T1 (de) Ausgangsprodukte zur herstellung von cephalosporinen und verfahren zu ihrer herstellung.
ATE285252T1 (de) Mittel zur verhinderung der truebung der vorderen linsenkapsel
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
TH43680A (th) เกลือเชอร์ทราลีนและรูปแบบการใช้ที่มีการหน่วงการปลดปล่อยของเซอร์ทราลีน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0871434

Country of ref document: EP